Acesion Pharma
Entity

  • Acesion Pharma

    Created in 2011
  • BETA

    Up & running (A)
    Existing signals show a regular activity

  • Social networks

    2,231

  • Activities

    deeptech biotech

  • Technologies

    Synthetic Biology

  • Entity types

    Startup

  • Location

    Ole Maaløes Vej 3, 2200 København, Denmark

    København

    Denmark

  • Employees

    Scale: 11-50

    Estimated: 19

  • Engaged corporates

    0
    0 0

  • Added in Motherbase

    1 year, 1 month ago
Description
  • Value proposition

    Danish biotech developing novel treatments for Atrial Fibrillation

    Acesion Pharma is a Danish biotech company founded in 2011. We are aiming to develop more efficacious and safer drugs for the treatment of atrial fibrillation (AF), the most common type of cardiac arrhythmia.
    The scientific foundation of Acesion Pharma is the novel concept of treating AF by inhibiting the so-called SK channels. These are ion channels present in the heart where they are relevant for regulating the cardiac rhythm. Blocking this ion channel with a selective drug molecule constitutes a novel and promising target for developing improved treatment of AF.

  • Home | Acesion Pharma

    Acesion Pharma ApS is a Danish biotech company founded in 2011 and based in Copenhagen. Acesion Pharma develops more efficacious and safe drugs for the treatment of atrial fibrillation (AF), the most common type of cardiac arrhythmia.

    • https://www.acesionpharma.com/
Corporate interactions BETA
Corporate TypeTweets Articles
No interactions
Similar entities
Last news
Show all articles
Social network dynamics